or Try an Advanced Search...

    Technical Analysis for VALN - Valneva SE

    Grade Last Price % Change Price Change
    F 4.56 -2.36% -0.11
    VALN closed up 2.41 percent on Wednesday, November 20, 2024, on 1.85 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical VALN trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish -2.36%
    Wide Bands Range Expansion -2.36%
    Oversold Stochastic Weakness -2.36%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 0.22%
    Doji - Bullish? Reversal 0.22%
    Older End-of-Day Signals for VALN ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 2 hours ago
    Lower Bollinger Band Support about 2 hours ago
    Down 5% about 3 hours ago
    New 52 Week Low about 3 hours ago
    Down 1 ATR about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    VALN Chart by TradingView
    Basic chart:

    Profile

    Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Infectious Diseases Vaccines Medical Research Vaccination Virology Lyme Disease

    Is VALN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department
    Nov 13 Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2
    Nov 12 Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
    Nov 9 Valneva SE (VALN) Q3 2024 Earnings Call Transcript
    Nov 8 Valneva SE (INRLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved ...
    Nov 7 Valneva reports nine-month results
    Nov 7 Valneva Reports Nine-Month 2024 Financial Results and Provides Corporate Updates
    Nov 6 VALNEVA - Declaration of shares and voting rights: October 31, 2024
    Oct 25 High Growth Tech Stocks in France to Watch October 2024
    Oct 24 Lectra And 2 Other High Growth Tech Stocks In France
    See more VALN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.96
    52 Week Low 4.45
    Average Volume 21,054
    200-Day Moving Average 7.17
    50-Day Moving Average 5.70
    20-Day Moving Average 5.37
    10-Day Moving Average 4.90
    Average True Range 0.23
    RSI (14) 29.58
    ADX 23.68
    +DI 21.33
    -DI 40.72
    Chandelier Exit (Long, 3 ATRs) 5.51
    Chandelier Exit (Short, 3 ATRs) 5.15
    Upper Bollinger Bands 6.42
    Lower Bollinger Band 4.32
    Percent B (%b) 0.17
    BandWidth 39.03
    MACD Line -0.35
    MACD Signal Line -0.28
    MACD Histogram -0.0755
    Fundamentals Value
    Market Cap 324.07 Million
    Num Shares 69.4 Million
    EPS -1.77
    Price-to-Earnings (P/E) Ratio -2.64
    Price-to-Sales 2.51
    Price-to-Book 3.47
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.95
    Resistance 3 (R3) 4.94 4.84 4.91
    Resistance 2 (R2) 4.84 4.76 4.84 4.89
    Resistance 1 (R1) 4.75 4.72 4.79 4.76 4.88
    Pivot Point 4.65 4.65 4.67 4.65 4.65
    Support 1 (S1) 4.56 4.57 4.61 4.58 4.46
    Support 2 (S2) 4.46 4.53 4.46 4.45
    Support 3 (S3) 4.37 4.46 4.43
    Support 4 (S4) 4.39